Hyogo, Japan

Tooru Tazima

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Denki Kabushiki Kaisha. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tooru Tazima: Innovator in Semiconductor Technology

Introduction

Tooru Tazima is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of semiconductor technology. His innovative work has led to the development of a unique semiconductor device that addresses critical challenges in the industry.

Latest Patents

Tooru Tazima holds 1 patent for a semiconductor device. This device comprises a semiconductor substrate and features a stress-buffering film. The film is effective in buffering the stress caused by a molding resin during sealing. It is made of a silicone ladder resin represented by a specific formula, where each end group may represent a hydrogen atom or an alkyl group. The side chains can vary and may include cyclohexyl groups, lower alkyl groups, or photopolymerizable unsaturated groups. The integer value of n is 10 or larger, indicating the complexity and robustness of the design.

Career Highlights

Tooru Tazima is associated with Mitsubishi Electric Corporation, where he has been instrumental in advancing semiconductor technologies. His work has not only contributed to the company's portfolio but has also had a lasting impact on the industry.

Collaborations

Tooru has collaborated with esteemed colleagues such as Shigeyuki Yamamoto and Etsushi Adachi. Their combined expertise has fostered innovation and development in semiconductor applications.

Conclusion

Tooru Tazima's contributions to semiconductor technology exemplify the spirit of innovation. His patent reflects a deep understanding of material science and engineering principles. His work continues to influence the field and inspire future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…